You are here: Home: LCU 1 | 2006 : Kathy S Albain, MD: Select publications
SELECT PUBLICATIONS
Albain KS et al. Phase III study of concurrent chemotherapy and radiotherapy (CT/RT)
vs CT/RT followed by surgical resection for Stage IIIA (PN2) non-small cell lung
cancer (NSCLC): Outcomes update of North American Intergroup 0139 (RTOG 9309). Presentation. ASCO 2005;Abstract 7014.
Albain KS et al. Phase III comparison of concurrent chemotherapy plus radiotherapy
(CT/RT) and CT/RT followed by surgical resection for Stage IIIA (PN2) non-small cell lung cancer (NSCLC): Initial results from the intergroup trial 0139 (RTOG 93-09). Presentation. ASCO 2003;Abstract 2497.
Herbst RS et al. Phase I/II trial evaluating the anti-vascular endothelial growth factor
monoclonal antibody bevacizumab in combination with the HER-1/epidermal growth
factor receptor tyrosine kinase inhibitor erlotinib for patients with recurrent non-small cell lung cancer. J Clin Oncol 2005;23(11):2544-55. Abstract
Sandler AB et al. Randomized phase II/III trial of paclitaxel (P) plus carboplatin (C)
with or without bevacizumab (NSC # 704865) in patients with advanced non-squamous
non-small cell lung cancer (NSCLC): An Eastern Cooperative Oncology Group
(ECOG) Trial E4599. Presentation. ASCO 2005;Abstract 4.
|
